Literature DB >> 30041593

Implantable cardioverter-defibrillator therapy in Australia, 2002-2015.

Bianca Blanch1, Luise P Lago2, Raymond Sy3, Phillip J Harris4, Christopher Semsarian5, Jodie Ingles.   

Abstract

OBJECTIVES: To quantify the number of implantable cardioverter-defibrillator (ICD) procedures in Australia by year, patient age and sex, and to estimate age group-specific population rates and the associated costs. Design, setting: Retrospective observational study; analysis of Australian National Hospital Morbidity Database hospital procedures data. PARTICIPANTS: Patients with an ICD insertion, replacement, adjustment, or removal procedure code, July 2002 - June 2015. MAIN OUTCOME MEASURES: Number of ICD procedures by procedure year, patient age (0-34, 35-69, 70 years or more) and sex; age group-specific population procedure rates; number of procedures associated with complications.
RESULTS: The number of ICD procedures increased from 1844 in 2002-03 to 6504 in 2014-15; more than 75% of procedures were in men. In 2014-15, the ICD insertion rate for people aged 70 years or more was 78.1 per 100 000 population, 22 per 100 000 for those aged 35-69 years, and 1.40 per 100 000 people under 35. The reported complication rate decreased from 45% in 2002-03 to 19% in 2014-15, partly because of a change in the coding of complications. The number of removals corresponded to at least 4% of the number of insertions each year. The aggregate cost of hospitalisations with an ICD procedure during 2011-14 was $445 644 566.
CONCLUSION: ICD procedures are becoming more frequent in Australia, particularly in people aged 70 or more. Patterns of care associated with ICD therapy, particularly patient- and hospital-related factors associated with adverse events, should be investigated to better understand and improve patient outcomes.

Entities:  

Keywords:  Cardiac electrophysiology; Cardiac surgery; Defibrillator

Mesh:

Year:  2018        PMID: 30041593     DOI: 10.5694/mja17.01183

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Changes in the Physical Function and Psychological Distress from Pre-Implant to 1, 6, and 12 Months Post-Implant in Patients Undergoing Implantable Cardioverter Defibrillator Therapy.

Authors:  JinShil Kim; Jin-Kyu Park; Jiin Choi; Sun Hwa Kim; Young Keun On; Mi-Seung Shin; NaYeon Choi; Seongkum Heo
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

2.  Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective.

Authors:  Nathan Engstrom; Geoffrey P Dobson; Kevin Ng; Hayley L Letson
Journal:  Front Cardiovasc Med       Date:  2020-10-27

Review 3.  Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment.

Authors:  Alexandra Butters; Neal K Lakdawala; Jodie Ingles
Journal:  Curr Heart Fail Rep       Date:  2021-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.